Recent clinical trials have shown that dual and triple agonists targeting these pathways can lead to superior reductions in body weight and liver fat compared to GLP-1R mono-agonists, with a comparable safety profile [16,17,18,19,20,21,22]
While branded medications like Ozempic, Zepbound, and Wegovy are FDA-approved, its important to clarify that compounded medications are not FDA-approved, though they are prepared in FDA-registered and inspected compounding pharmacies
From restrictive fad diets to intentionally consuming tapeworm parasites, theres no shortage of outrageous and dangerous things people do in hopes of losing weight quickly. But, despite social and cultural pressures to be the thinnest version of yourself, obesity rates across America are the highest theyve ever been. Based on 20172020 data, the Centers for Disease Control and Prevention (CDC) report that 41.9% of American adults have obesity. Being an adult with obesity means that your Body Mass Index (BMI) also known as height to weight ratio falls outside a healthy range
Our model also suggests that GLP-1 M treatment combined with sulfonylureas or thiazolidinediones has no added benefit and may actually decrease treatment effectiveness
